CME Group Inc. $CME Shares Acquired by Tidal Investments LLC

Tidal Investments LLC boosted its holdings in CME Group Inc. (NASDAQ:CME) by 1.2% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 161,957 shares of the financial services provider’s stock after acquiring an additional 1,851 shares during the period. Tidal Investments LLC’s holdings in CME Group were worth $35,765,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CME. Whipplewood Advisors LLC grew its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership bought a new stake in shares of CME Group in the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in shares of CME Group in the 4th quarter worth approximately $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in CME Group during the 2nd quarter valued at approximately $28,000. Finally, Bayban acquired a new position in CME Group during the 4th quarter valued at approximately $31,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Shareholder distribution: CME is scheduled to distribute approximately $467 million in dividends on September 25, reinforcing its appeal to income-oriented investors and highlighting the exchange operator’s strong cash-generation profile. CME Group’s $467 Million Dividend: What Shareholders Collect Sept. 25
• Positive Sentiment: Product expansion: CME’s new single-stock futures offer investors leveraged and capital-efficient exposure to individual equities. The product broadens CME’s equity derivatives lineup and could create additional trading volume and fee revenue over time. CME’s New Single Stock Futures: What Are The Advantages Vs. Stocks?
• Positive Sentiment: European market entry: CME plans to enter the European dairy market through a deal involving EEX, expanding its addressable market and potentially improving its international commodities presence. CME Group to enter European dairy market through EEX deal
• Neutral Sentiment: Leadership succession: CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. The planned internal transition may provide continuity, although investors could monitor execution during the leadership change. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Interest-rate backdrop: Reports that Federal Reserve Chair Warsh favors rate hikes, while the Treasury considers buying longer-maturity debt, point to continued uncertainty over rates, inflation and bond-market conditions. These factors can affect CME’s interest-rate and fixed-income trading volumes. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation: The Hyperliquid Policy Center filed an amicus brief urging dismissal of CME’s lawsuit against the CFTC. The development adds uncertainty to CME’s regulatory position and could weigh on sentiment surrounding its digital-asset and derivatives initiatives. Hyperliquid Policy Center Files Amicus Brief Urging Dismissal of CME’s Suit Against CFTC

Insider Transactions at CME Group

In other news, Director William Shepard purchased 325 shares of the stock in a transaction dated Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on CME. JPMorgan Chase & Co. increased their target price on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research report on Thursday, July 23rd. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a research report on Thursday, June 18th. Piper Sandler reduced their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Finally, Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $289.75.

CME Group Stock Performance

CME stock opened at $274.70 on Thursday. The company has a market capitalization of $98.78 billion, a P/E ratio of 23.30, a PEG ratio of 3.29 and a beta of 0.24. The company has a 50-day simple moving average of $262.03 and a 200 day simple moving average of $277.67. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter last year, the company earned $2.96 EPS. CME Group’s quarterly revenue was up .8% on a year-over-year basis. Sell-side analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is 44.11%.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.